56974-46-0|Butalamine HCl|N1,N1-dibutyl-N2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine hydrochloride|-范德生物科技公司

Butalamine HCl

NMR下载 COA and HPLC MSDS下载
names：
N1,N1-dibutyl-N2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine hydrochloride
CAS号：
56974-46-0
MDL Number：
MF(分子式)： C18H29ClN4O MW(分子量)： 352.9
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Butalamine HCl
英文别名	Butalamine hydrochloride; Butalamine HCl; Adrevil; LA 1221; Hemotrope;
CAS号	56974-46-0
Inchi	InChI=1S/C18H28N4O.ClH/c1-3-5-13-22(14-6-4-2)15-12-19-18-20-17(21-23-18)16-10-8-7-9-11-16;/h7-11H,3-6,12-15H2,1-2H3,(H,19,20,21);1H
InchiKey	ZCEDBAQIHPGWNW-UHFFFAOYSA-N
分子式 Formula	C18H29ClN4O
分子量 Molecular Weight	352.9
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Butalamine HCl(CAS:56974-46-0):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Butalamine HCl is a vasodilator (peripheral) with local anesthetic effects. Butalamine HCl has been shown to inhibit state 3 respiration and decrease ADP/O in rat liver.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Tine J, Junien JL. Effects of butalamine on oxydative phosphorylations in the rat liver. Arzneimittelforschung. 1976;26(9):1677-80. PubMed PMID: 826262.

[2]Morgon A. [Test of butalamine in labyrinth diseases]. JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac. 1976 May;25(5):395-8. French. PubMed PMID: 133207.

[3] Traissac L. [Clinical trial of butalamine]. Rev Laryngol Otol Rhinol (Bord). 1973 Sep-Oct;94(9):465-72. French. PubMed PMID: 4603409.

[4] Coupar IM, Hedges A, Metcalfe HL, Turner P. Effect of aminophylline, butalamine and imolamine on human isolated smooth muscle. J Pharm Pharmacol. 1969 Jul;21(7):474-5. PubMed PMID: 4390076.

[5] Zeitler E. [Xenon-133 muscle clearance before and after butalamine hydrochloride. Results of a double blind test]. Fortschr Med. 1976 Dec 2;94(34):2055-8. German. PubMed PMID: 826469.

6: Sterne J. [Prolonged treatment of obliterantive arteritis with butalamine. Follow up study of 42 cases during more than 1 year of rheographic control]. Rev Clin Esp. 1979 Oct 31;155(2):123-6. Spanish. PubMed PMID: 119287.7: Sterne J. [Butalamine hydrochloride. A new vasoactive substance]. Fortschr Med. 1976 Apr 15;94(11):657-9. German. PubMed PMID: 823083.8: Seboldt H. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride]. Fortschr Med. 1980 Feb 21;98(7):257-60. German. PubMed PMID: 6767648.9: Zmigrodzka K. [Surheme (Butalamine) in the treatment of vertigo]. Otolaryngol Pol. 1976;30(3):227-33. Polish. PubMed PMID: 823509.10: Kling H. [Drug therapy of chronic arterial occlusive diseases of the lower extremities with butalamine-HCl]. Fortschr Med. 1979 May 17;97(19):926-8. German. PubMed PMID: 109382.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开